ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.

Tamer A ElBayoumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.